Quazi T. H. Shubhra
Assistant Professor: Institute of Chemistry, University of Silesia, Poland
\
Contact:
tanminul-haque-shubra.quazi@us.edu.pl
shubhro.du@gmail.com
GoogleScholar ResearchGate ORCID LinkedIn X
EDITORIAL BOARD MEMBERSHIP:
Associate Editor: Journal of Translational Medicine (IF 9.7); BJC Reports (IF 3.8)
Youth Editor: Research (IF 12.9); Nano Materials Science (IF 20.5)
Editorial board member: Communications Medicine (IF 7.4), Discover Nano (IF 6.7), Med Research, Innovation Drug Discovery, Discover Oncology, Health Nanotechnology, Discover Chemistry, + more
Selected articles:
*Quazi T. H. Shubhra, Xiaojun Cai. Mixing Metals with MXenes; Nature Reviews Chemistry, 2024, 8, 877–878. (IF 50.3) LINK
Qiang Cai*, Xiaojun Cai, Quazi T. H. Shubhra*. Mitochondrial transfer drives immune evasion in tumor microenvironment. Trends in Cancer, 2025, 11(5), 424-426. (IF 21.6) Link
*Kai Guo#, Yixuan Liu#, Lirui Tang, *Quazi T. H. Shubhra. Homotypic Biomimetic Coating Synergizes Chemo-Photothermal Combination Therapy to Treat Breast Cancer Overcoming Drug Resistance; Chemical Engineering Journal, 2022, 428, 131120. (IF 12.5) LINK
Hongyang Lu, Qiang Zhou, Jiayu Li, Shengming Xu, Li Yu, Yinci Zhu, He Zhang, Chengge Shi, Tianci Zuo, Mengzhu Xu, Mingli Su, Yanmei Zhang, Rongdang Hu, *Quazi T. H. Shubhra, *Hui Deng, *Xiaowen Hu, *Xiaojun Cai. CO-Releasing Polyoxometalates Nanozyme with Gut Mucosal Immunity and Microbiota Homeostasis Remodeling Effects for Restoring Intestinal Barrier Integrity. Advanced Science, 2025, 12(17), 2500116. (IF 14.1) LINK
*#Qiang Cai, #Yihao Tian, *Quazi T. H. Shubhra. Targeting Metabolic Circuitry to Supercharge CD8+ T Cell Antitumor Responses; Cell Metabolism, 2024, 36(5), 884-886. (IF 37.0) Link
*Quazi T. H. Shubhra, Qiang Cai. Advancing Rectal Cancer Therapy: mFOLFIRINOX Reduces Metastasis and Improves Survival Outcomes; Annals of Oncology; 2024, 35(11), 1062-1063. (IF 80.4) LINK
*#Qiang Cai, #Yihao Tian, *Quazi T. H. Shubhra. Pre-Activated Macrophage Membrane-Encased Aggregation-induced Emission Featuring Nanoparticles: A Novel Possibility for Tuberculosis Treatment; Signal Transduction and Targeted Therapy 2024, 9, 164, DOI: 10.1038/s41392-024-01855-8. (Impact Factor 81.2) LINK
